Opioid Treatment: Expanding Methadone Access to Pharmacies
The Modernizing Opioid Treatment Access Act 2.0 of 2026 is in the early stages of the legislative process. It has not moved since July 20, 2026, when it was sent to the House Energy and Commerce and Judiciary committees for review. These committees must take action before the bill can move forward, though most bills do not receive a committee vote.
Companion bill: Sen. Markey and Sen. Paul Push to Let Local Pharmacies Dispense Methadone for Addiction →This bill has support from both parties and addresses a major health crisis, but similar changes have faced pushback from clinic owners in the past.
This bill’s path across every version that has carried it.
Companion
Identical companion bill S. 4941 (119th) was introduced in the other chamber.
S. 4941 (119th) →Scores run from -100 (strongly harmful) to +100 (strongly beneficial) for each group, combining impact, certainty, scope, and duration ratings of 1-5. How impact scoring works
Veterans have higher than average rates of opioid use disorder tied to combat injuries and chronic pain. Easier pharmacy access to methadone, including through telemedicine, could help veterans in rural areas or those far from VA clinics stay in treatment, though the bill does not specifically mention veterans or VA programs.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Sent to a congressional committee for expert review. The committee decides whether this bill moves forward.
Introduced in House
The bill was officially filed and given a number. It now enters the legislative queue.
A new bipartisan Senate bill, the Modernizing Opioid Treatment Access Act 2.0, aims to allow addiction specialists to prescribe methadone for pickup at local pharmacies, potentially ending the 50-year 'clinic-only' model for opioid treatment in the United States.
Senators Ed Markey and Rand Paul reintroduced legislation to expand methadone access. The bill would permit board-certified addiction physicians to prescribe the medication for pharmacy dispensing, addressing the fact that 80% of U.S. counties lack a specialized treatment clinic.
The American Society of Addiction Medicine (ASAM) has applauded the introduction of MOTAA 2.0, which aims to reduce fragmentation in addiction care by allowing expert clinician prescribing and pharmacy dispensing of methadone.
No votes recorded for this bill yet.
Document Type
Congressional Bill
Official Title
Modernizing Opioid Treatment Access Act 2.0 of 2026
Analysis generated by AI. Always verify with official sources.